Literature DB >> 15549226

[Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].

C Stroszczynski1, G Gaffke, M Gnauck, F Streitparth, G Wieners, E Lopez-Häninnen.   

Abstract

The contrast agents Gd-EOB-DTPA and Gd-BOPTA can be administered by bolus injection and are appropriate for use in MRI both as vascularization markers and markers of hepatobiliary excretion. This contribution presents an overview of the specific characteristics of contrast media and the status of clinical development. In comparison to CT and to MRI with unspecific extracellular Gd-chelates, liver-specific contrast agents offer advantages in differentiating unclear liver lesions, increasing the detection rate, and examining the bile duct system.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15549226     DOI： 10.1007/s00117-004-1134-5

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


  31 in total

1.  Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

Authors:  J Petersein; A Spinazzi; A Giovagnoni; P Soyer; F Terrier; R Lencioni; C Bartolozzi; L Grazioli; A Chiesa; R Manfredi; P Marano; E L Van Persijn Van Meerten; J L Bloem; C Petre; G Marchal; A Greco; M T McNamara; A Heuck; M Reiser; M Laniado; C Claussen; H E Daldrup; E Rummeny; M A Kirchin; G Pirovano; B Hamm
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis.

Authors:  A Tanimoto; Y Satoh; Y Yuasa; M Jinzaki; K Hiramatsu
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

Authors:  W Stern; F Schick; A F Kopp; P Reimer; K Shamsi; C D Claussen; M Laniado
Journal:  Acta Radiol       Date:  2000-05       Impact factor: 1.990

4.  Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.

Authors:  R Kuwatsuru; M Kadoya; K Ohtomo; A Tanimoto; S Hirohashi; T Murakami; Y Tanaka; K Yoshikawa; H Katayama
Journal:  Invest Radiol       Date:  2001-11       Impact factor: 6.016

5.  Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.

Authors:  Young Kon Kim; Chong Soo Kim; Young Hwan Lee; Hyo Sung Kwak; Jeong Min Lee
Journal:  AJR Am J Roentgenol       Date:  2004-05       Impact factor: 3.959

6.  Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient?

Authors:  Ruth C Carlos; Jill D Branam; Qian Dong; Hero K Hussain; Isaac R Francis
Journal:  Acad Radiol       Date:  2002-11       Impact factor: 3.173

7.  Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.

Authors:  G Marchal; X Zhang; Y Ni; P Van Hecke; J Yu; A L Baert
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

8.  Contrast-enhanced MR angiography in rats with hepatobiliary contrast agents.

Authors:  Kohki Yoshikawa; Yusuke Inoue; Morio Shimada; Masaaki Akahane; Sayaka Itoh; Atsushi Seno; Sanshin Hayashi
Journal:  Magn Reson Imaging       Date:  2004-09       Impact factor: 2.546

9.  MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings.

Authors:  Y Ni; G Marchal; G Lukito; J Yu; A Mühler; A L Baert
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

10.  [Current concepts and recent developments of laser ablation in tumor therapy].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; R Puls; N Hosten; U Speck; J Ricke; H Oettle; P Hohenberger; R Felix
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635
View more
  5 in total

Review 1.  [Diagnostic radiology of liver tumors. Part 1: General disease aspects and radiological procedures].

Authors:  G Layer; M Bohrer
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

2.  Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.

Authors:  Julia Greiser; Tobias Niksch; Wolfgang Weigand; Martin Freesmeyer
Journal:  J Vis Exp       Date:  2016-08-17       Impact factor: 1.355

3.  Peritumoral Imaging Manifestations on Gd-EOB-DTPA-Enhanced MRI for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ying Wu; Meilin Zhu; Yiming Liu; Xinyue Cao; Guojin Zhang; Longlin Yin
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 4.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

5.  [Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA. Preliminary experience and clinical applications].

Authors:  K Holzapfel; C Breitwieser; C Prinz; E J Rummeny; J Gaa
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.